GSK2983559 free acid
CAS No. 1579965-12-0
GSK2983559 free acid ( —— )
产品货号. M26238 CAS No. 1579965-12-0
GSK2983559 free acid is an effective and selective inhibitor of receptor-interacting protein 2 (RIP2).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥786 | 有现货 |
|
10MG | ¥1215 | 有现货 |
|
25MG | ¥2033 | 有现货 |
|
50MG | ¥3038 | 有现货 |
|
100MG | ¥4560 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称GSK2983559 free acid
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述GSK2983559 free acid is an effective and selective inhibitor of receptor-interacting protein 2 (RIP2).
-
产品描述GSK2983559 free acid is an effective and selective inhibitor of receptor-interacting protein 2 (RIP2). GSK2983559 free acid shows excellent activity in blocking many proinflammatory cytokine responses in human inflammatory bowel disease explant samples.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体leucyl-tRNA synthetase; Ras-related GTP-binding protein D (RagD)
-
研究领域——
-
适应症——
化学信息
-
CAS Number1579965-12-0
-
分子量538.5
-
分子式C21H23N4O7PS2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCOP(O)(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Jong Hyun Kim, et al. Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction. Nat Commun. 2017 Sep 29;8(1):732.
产品手册
关联产品
-
Soyasapogenol A
Soyasapogenol A shows estrogenic and hepatoprotective activities, it directly prevents apoptosis of hepatocytes, and secondly, inhibits the elevation of plasma TNF-α±, which consequently resulted in the prevention of liver damage in the concanavalin A-induced hepatitis model.
-
Tocofersolan
Tocofersolan is a polyethylene glycol derivative of α-tocopherol and synthetic water-soluble version of Tocopherol.
-
Naringenin triacetat...
Naringenin triacetate exhibits a better binding affinity with multiple crystal structures of first bromodomain BRD4 (BRD4 BD1) when compared with the known inhibitors.